Status:
NOT_YET_RECRUITING
Hypoproteic Diet in Acromegaly
Lead Sponsor:
Azienda Ospedaliero Universitaria Maggiore della Carita
Conditions:
Acromegaly
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Since protein and AAs are master regulator of GH and IGF-I secretion, we hypothesized that a low protein diet could reduce GH and IGF-I levels in acromegalic patients in addition to conventional thera...
Detailed Description
Nutrients are crucial modifiers of the GH/IGF-I axis. In particular, a close cross-talk between proteins and amino acids (AAs) and GH/IGF-I secretion exists. Both AAs and proteins affect GH secretion...
Eligibility Criteria
Inclusion
- Age 18/65
- Diagnosis of Acromegaly
- In therapy with somatostatin analogues
Exclusion
- pregnancy or lactation
- alchool or drugs abuse
- cancer
- Hematological diseases
Key Trial Info
Start Date :
September 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT05298891
Start Date
September 1 2024
End Date
March 1 2026
Last Update
September 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
: Italy Pediatric Endocrine Service of AOU Maggiore della Carità of Novara; SCDU of Pediatrics, Department of Health Sciences, University of Eastern Piedmont
Novara, Italy, 28100